Patents by Inventor Jon Lorenz

Jon Lorenz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050222134
    Abstract: Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 6, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Carl Busacca, Michael Cerreta, Richard Varsolona, John Smoliga, Jon Lorenz, Jana Vitous
  • Publication number: 20050203314
    Abstract: This invention provides a method for generating secondary phosphines from secondary phosphine oxides in the presence of a reducing agent, such as diisobutylaluminum hydride (DIBAL-H), triisobutyldialuminoxane, triisobutylaluminum, tetraisobutyldialuminoxane, or another reducing agent comprising: (i) an R1R2AlH moiety, wherein R1 and R2 are each an alkyl species or oxygen, and wherein at least one of R1 or R2 comprises at least 2 carbon atoms, or (ii) an R1R2R3Al moiety, wherein R1, R2, and R3 are not hydrogen, and wherein at least one of R1, R2, and R3 is an alkyl species comprising a ?-hydrogen, not including triethylaluminum. Preferred reducing agents for the present invention include: diisobutylaluminum hydride, triisobutyldialiuminoxane, triisobutylaluminum, tetraisobutyldialuminoxane, and combinations thereof.
    Type: Application
    Filed: January 12, 2005
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Carl Busacca, Jon Lorenz
  • Publication number: 20050113572
    Abstract: Disclosed are processes of making dipeptide compounds of formula(I) as further described in the detailed description section:
    Type: Application
    Filed: October 27, 2004
    Publication date: May 26, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Carl Busacca, Nizar Haddad, Suresh Kapadia, Lana Smith Keenan, Jon Lorenz, Chris Senanayake, Xudong Wei